5285-16-5 Usage
Derivative of pyrazole
Yes
Used in synthesis of pharmaceuticals and organic compounds
Yes
Potential applications
Medicine, agriculture, and materials science
Interesting properties
Yes
Valuable tool for researchers and chemists
Yes
1H-Pyrazol-3-amine, 4,5-dihydro-1,5-diphenylis a chemical compound with the molecular formula C18H16N4. It is a derivative of pyrazole, which is a five-membered heterocyclic compound containing one nitrogen atom and one ring-forming carbon atom. The compound is used in the synthesis of various pharmaceuticals and organic compounds, making it a valuable building block for the development of novel drugs and materials. Its potential applications span across the fields of medicine, agriculture, and materials science, highlighting its versatility and importance. The compound's interesting properties make it a useful tool for researchers and chemists working in diverse fields, allowing for the creation of new compounds and materials with unique properties.
Check Digit Verification of cas no
The CAS Registry Mumber 5285-16-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,2,8 and 5 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5285-16:
(6*5)+(5*2)+(4*8)+(3*5)+(2*1)+(1*6)=95
95 % 10 = 5
So 5285-16-5 is a valid CAS Registry Number.
5285-16-5Relevant academic research and scientific papers
Therapeutically active 3-amino-1-phenyl(and substituted phenyl)-2-pyrazolines
-
, (2008/06/13)
This disclosure describes certain 3-amino-1-phenyl-2-pyrazolines and 3-amino-1-substituted phenyl-2-pyrazolines and their C4 and C5 analogs useful for meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, or as analgesic, antibacterial or antifungal agents.
3-Trifluoroacetylamino-1-aryl-2-pyrazolines
-
, (2008/06/13)
This disclosure describes novel 3-substituted amino-1-phenyl-2-pyrazolines and 3-substituted amino-1-mono and disubstituted phenyl-2-pyrazolines and their C4 and C5 analogs, useful for meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease, preventing the onset of asthmatic symptoms and allergic diseases, or as analgesic, antibacterial or antifungal agents.
